建立中高危前列腺癌卫星病灶的分布:对聚焦放疗的意义
回顾性单中心研究纳入2012年1月至12月接受mpMRI后行根治性前列腺切除术的71例临床局限期中高危前列腺癌患者,分析术前预测卫星病灶的因素及mpMRI检测效能。结果显示66.2%的根治标本存在卫星病灶,mpMRI检出敏感度59.6%、特异度66.7%、准确率62.0%,仅mpMRI卫星病灶为术前显著预测因素(HR 2.95,P=0.040)。结合活检与mpMRI信息在全队列中单侧与双侧病变一致率为76.1%。
要点
- 根治标本中66.2%存在卫星病灶,其中55.3%的卫星病灶病理Gleason评分≥3+4。
- mpMRI检出卫星病灶的敏感度59.6%、特异度66.7%、阳性预测值77.8%、阴性预测值45.7%、准确率62.0%。
- 仅mpMRI卫星病灶为最终病理卫星病灶的显著术前预测因素(HR 2.95,P=0.040)。
核心结论
- 在中危及以上前列腺癌中,仅mpMRI卫星病灶的存在可预测病理卫星病灶。
- 结合活检与mpMRI信息可能改善术前病变定位,但病理Gleason评分≥7的卫星病灶导致双侧半腺受累发生率较高,使筛选适合半腺治疗的患者具有挑战性。
研究设计与样本
- 回顾性单中心研究纳入71例连续临床局限期中危或高危前列腺癌患者,于2012年1月至2012年12月接受mpMRI后行根治性前列腺切除术。
- 采用逻辑回归分析评估卫星病灶的术前预测因素,并评估mpMRI检测卫星病灶及病变范围(单侧半腺 vs 双侧)的效能。
主要发现
- 全队列中50.7%在mpMRI上存在卫星病灶;根治标本分析中66.2%存在卫星病灶,其中55.3%的卫星病灶病理Gleason评分≥3+4。
- mpMRI检测根治标本中卫星病灶存在的敏感度59.6%、特异度66.7%、阳性预测值77.8%、阴性预测值45.7%、准确率62.0%。
- mpMRI卫星病灶的存在是唯一与最终病理发现卫星病灶显著相关的术前预测因素(HR 2.95,P=0.040)。
- 结合活检与mpMRI信息判断单侧 vs 双侧病变,与根治标本比较,全队列一致率为76.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In focused radiotherapy for prostate cancer (PC), a full dose of radiation is delivered to the index lesion while reduced dose is delivered to the remaining prostate to reduce morbidity. As PC is commonly multifocal, we investigated whether baseline clinical characteristics or multiparametric magnetic resonance imaging (mpMRI) may be useful to predict the actual pathologic distribution of PC in men with intermediate- or high-risk PC, which may better inform how to deliver focused radiotherapy. METHODS: A retrospective single-institutional study was performed on 71 consecutive men with clinically localized, intermediate- or high-risk PC who underwent mpMRI followed by radical prostatectomy (RP) from January 2012 to December 2012. Logistic regression analysis was performed to evaluate preoperative predictors for satellite lesions. Performance characteristics of mpMRI to detect satellite lesions and the extent of prostate disease (one hemi-gland vs both) were also evaluated. RESULTS: In all, 50.7% had satellite lesions on mpMRI. On RP specimen analysis, 66.2% had satellite lesions and 55.3% of these satellite lesions had pathologic Gleason score (pGS)⩾3+4. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for mpMRI detecting a satellite lesion being present in the RP specimen were 59.6%, 66.7%, 77.8%, 45.7% and 62.0%, respectively. The presence of MRI satellite lesions was the only preoperative predictor significantly associated with finding satellite lesions on final pathology (hazard ratio (HR), 2.95, P=0.040). There was agreement in 76.1% of the entire cohort for unilateral vs bilateral disease when incorporating both biopsy and mpMRI information and comparing with the RP specimen. CONCLUSIONS: In intermediate risk or greater PC, only the presence of mpMRI satellite lesions could predict for pathologic satellite lesions. While combining biopsy and mpMRI information may improve preoperative disease localization, the relatively high incidence of bilateral hemi-gland involvement with pGS ⩾7 satellite lesions makes it challenging to appropriately select men eligible for hemi-gland therapy.
引用
- Hegde JV, Margolis DJ, Wang PC, et al. Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy. Prostate Cancer Prostatic Dis. 2017. PMID: 28139757. doi:10.1038/pcan.2016.75
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。